ETF Copilot
Health & Biotech

Is FMED a good investment?

Updated October 9, 2026

Fidelity Disruptive Medicine ETF (FMED) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores FMED 4.7 out of 10 — highest on Value (7.5), lowest on Quality (0.4). It trades at 38.5 times earnings, against its own median of 40.1.

What stands out in FMED's data

A focused health-science strategy targeting disruptive medicine companies.

Its portfolio companies are far less profitable than typical health-sector peers.

EBITDA margin of 14.1% is exceptionally low versus the category median of 20.5%.

A speculative sleeve for a health-care allocation, betting on future breakthroughs over current profitability.

Why did FMED move this week? It fell 1.3% in the week to October 9, 2026 — 10X Genomics and Argenx SE drove it

FMED fell 1.3% in the week to October 9, 2026. The holdings that moved it most were 10X Genomics (−13.7%), Argenx SE (−10.2%) and Twist Bioscience (−15.3%); Vaxcyte (+26.4%) pushed the other way.

How is FMED rated? ETF Copilot scores Fidelity Disruptive Medicine ETF (FMED) 4.7 out of 10

As of October 9, 2026, ETF Copilot scores Fidelity Disruptive Medicine ETF (FMED) 4.7 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

  • Overall: 4.7 / 10
  • Growth: 6.8 / 10
  • Value: 7.5 / 10
  • Risk: 4.7 / 10
  • Quality: 0.4 / 10
  • Return: 3.7 / 10

Is FMED expensive right now? It trades at 38.5 times earnings, against its own median of 40.1

As of October 9, 2026, FMED is cheaper than 74% of its own last 3 years.

Trailing 12 months, built from FMED's holdings. How we calculate this →

What is FMED's expense ratio? 0.50% a year

As of October 9, 2026, FMED charges 0.50% a year and holds $50M in assets.

Fidelity Disruptive Medicine ETF (FMED) — cost, income and size
MeasureFMED
Expense ratio0.50%
Assets under management$50M

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Cite this

ETF Copilot, “Fidelity Disruptive Medicine ETF (FMED) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/fmed

ETF Copilot Pro unlocks FMED's price and holdings.

Try Pro free →